December 2025 in “International Journal of Dermatology” In 2025, the journal focused on diverse, inclusive dermatology research and shared knowledge through various media.
December 2025 in “Zenodo (CERN European Organization for Nuclear Research)” Hair loss is caused by mechanical, thermal, and metabolic factors, not just hormones.
December 2025 in “Medicine - Programa de Formación Médica Continuada Acreditado” Recent advancements in hair loss treatments include new therapies and insights for different types of alopecia.
November 2025 in “Cancers” Men with male pattern baldness may have a slightly higher risk of prostate cancer.
November 2025 in “Dermatology Reports” Microinfusion using tattoo devices effectively treats hair loss and skin conditions with minimal side effects.
October 2025 in “Journal of the Endocrine Society” A rare pituitary tumor in an 18-year-old male caused hormonal issues and vision loss, requiring surgery and further treatment.
September 2025 in “Journal of Cutaneous and Aesthetic Surgery” Scalp micropigmentation improves appearance and satisfaction in scarring alopecia but may require repeat sessions.
September 2025 in “Surgeries” Hair transplants can work for stable cicatricial alopecia, but success varies by condition.
August 2025 in “Frontiers in Immunology” Primary cicatricial alopecia is linked to various health issues, indicating broader systemic problems.
August 2025 in “Skin Appendage Disorders” TCM is an effective and safe treatment for primary cicatricial alopecias.
July 2025 in “Russian Journal of Skin and Venereal Diseases” Lichen planus on the scalp can cause scarring hair loss and has four main types.
July 2025 in “Revista Eletrônica Acervo Científico” Hydroxychloroquine is most effective for scarring alopecias, especially when combined with other treatments.
June 2025 in “British Journal of Dermatology” Low-dose oral minoxidil is increasingly used by dermatologists in the UK and Ireland to treat various hair loss conditions.
June 2025 in “British Journal of Dermatology” People with hair loss feel distressed and need better, trustworthy information sources.
June 2025 in “British Journal of Dermatology” Lichen planopilaris may have a genetic link.
June 2025 in “British Journal of Dermatology” Patients face long waits and misdiagnoses before getting proper hair loss treatment.
June 2025 in “JEADV Clinical Practice” Scarring alopecia is linked to higher rates of vitamin D deficiency, metabolic issues, mental health problems, thyroid disease, and other health conditions.
Alopecia is caused by hormones, microorganisms, and immune issues.
May 2025 in “Actas Dermo-Sifiliográficas” Botulinum toxin is not effective for treating androgenetic alopecia.
March 2025 in “Cosmetics” Combining treatments works best for early hair loss, while transplants are best for severe cases.
March 2025 in “JEADV Clinical Practice” People with primary scarring alopecia have higher risks of other health issues like vitamin D deficiency and thyroid disease.
January 2025 in “Surgical & Cosmetic Dermatology” Histopathological confirmation is crucial to accurately diagnose alopecia triangular temporal and avoid unnecessary treatments.
January 2025 in “International journal of research studies in biosciences” Mitochondrial dysfunction and oxidative stress may play a role in Lichen Planopilaris.
January 2025 in “Majmaah Journal of Health Sciences” Nearly 70% of postmenopausal women in Saudi Arabia experience hair loss, often linked to early menopause, chronic diseases, family history, and stress.
January 2025 in “International Journal of Trichology” Pattern hair loss is the most common type of alopecia.
Hair intradermotherapy effectively treats hair loss and boosts self-esteem.
November 2024 in “Dermatology Online Journal” Light-based therapies show promise as safe treatments for hair loss.
November 2024 in “Skin Appendage Disorders” Google trends show varying interest in alopecia types, but it's not a reliable health measure.
October 2024 in “Dermatology Practical & Conceptual” Trichoscopy effectively diagnoses eyebrow hair loss in certain conditions.
October 2024 in “JAAD Case Reports” Dutasteride mesotherapy showed mixed results and is not recommended as a primary treatment for hair loss.